Real-World Outcomes After Switching to Faricimab in Patients with Chronic Diabetic Macular Edema at a Tertiary Eye Center in Singapore.

Fukutsu K, Goh RA, Zheng F, Ong C, Tan ACS, Cheung GCM, SNEC Retina Research Group, Tan GSW

Open source

DOI
10.1007/s40123-026-01406-0
Published
2026 Jul
Container
Ophthalmology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40123-026-01406-0,
  title = {Real-World Outcomes After Switching to Faricimab in Patients with Chronic Diabetic Macular Edema at a Tertiary Eye Center in Singapore.},
  author = {Fukutsu K and Goh RA and Zheng F and Ong C and Tan ACS and Cheung GCM and SNEC Retina Research Group and Tan GSW},
  year = {2026},
  journal = {Ophthalmology and therapy},
  doi = {10.1007/s40123-026-01406-0},
  url = {https://doi.org/10.1007/s40123-026-01406-0}
}

RIS

TY  - JOUR
TI  - Real-World Outcomes After Switching to Faricimab in Patients with Chronic Diabetic Macular Edema at a Tertiary Eye Center in Singapore.
AU  - Fukutsu K
AU  - Goh RA
AU  - Zheng F
AU  - Ong C
AU  - Tan ACS
AU  - Cheung GCM
AU  - SNEC Retina Research Group
AU  - Tan GSW
PY  - 2026
JO  - Ophthalmology and therapy
DO  - 10.1007/s40123-026-01406-0
UR  - https://doi.org/10.1007/s40123-026-01406-0
ER  - 

APA

K, F., RA, G., F, Z., C, O., ACS, T., GCM, C., Group, S. R. R., & GSW, T. (2026). Real-World Outcomes After Switching to Faricimab in Patients with Chronic Diabetic Macular Edema at a Tertiary Eye Center in Singapore.. Ophthalmology and therapy. https://doi.org/10.1007/s40123-026-01406-0

Source records